參考文獻/References:
[1] DE COCK E,HANNON H,MOERMAN V,et al.Statin-induced myopathy:a case report[J].Eur Heart J Case Rep,2018,2(4):yty130.
[2] MAJI D,SHAIKH S,SOLANKI D,et al.Safety of statins[J].Indian J Endocrinol Metab,2013,17(4):636-646.
[3] VILLA L,LERARIO A,CALLONI S,et al.Immune-mediated necrotizing myopathy due to statins exposure[J].Acta Myol,2018,37(4):257-262.
[4] VAUGHAN C J,GOTTO A M Jr.Update on statins:2003[J].Circulation,2004,110(7):886-892.
[5] QU H,GUO M,CHAI H,et al.Effects of coenzyme Q10 on statin-induced myopathy:an updated meta-analysis of randomized controlled trials[J].J Am Heart Assoc,2018,7(19):e009835.
[6] BANACH M,RIZZO M,TOTH P P,et al.Statin intolerance—an attempt at a unified definition.Position paper from an International Lipid Expert Panel[J].Arch Med Sci,2015,11(1):1-23.
[7] PATEL J,MARTIN S S,BANACH M.Expert opinion:the therapeutic challenges faced by statin intolerance[J].Expert Opin Pharmacother,2016,17(11):1497-1507.
[8] PENNISI M,DI BARTOLO G,MALAGUARNERA G,et al.Vitamin D serum levels in patients with statin-induced musculoskeletal pain[J].Dis Markers,2019:3549402.
[9] LOWE K,KUBRA K T,HE Z Y,et al.Vitamin D supplementation to treat statin-associated muscle symptoms:a review[J].Sr Care Pharm,2019,34(4):253-257.
[10] 路海棠.他汀類藥物致肌病的臨床特點[J].臨床薈萃,2015,30(12):1378-1381.
[11] AGRAWAL D,MANCHANDA S C,SAWHNEY J P S,et al.To study the effect of high dose Atorvastatin 40mg versus 80mg in patients with dyslipidemia[J].Indian Heart J,2018,70(Suppl 3):S8-S12.
[12] KANDZIA I,KOWAR M,FRACKOWIAK M,et al.Simvastatin-induced myopathy after dose increase[J].Dtsch Med Wochenschr,2018,143(24):1791-1794.
[13] CHATZIZISIS Y S,KOSKINAS K C,MISIRLI G,et al.Risk factors and drug interactions predisposing to statin-induced myopathy:implications for risk assessment,prevention and treatment[J].Drug Saf,2010,33(3):171-187.
[14] KIDO K,OYEN A A,BECKMANN M A,et al.Musculoskeletal toxicities in patients receiving concomitant statin and daptomycin therapy[J].Am J Health Syst Pharm,2019,76(4):206-210.
[15] BRUCKERT E,HAYEM G,DEJAGER S,et al.Mildtomoderate muscular symptoms with high-dosage statin therapy in hyperlipidemicpatients-the PRIMO study[J].Cardiovasc Drugs Ther,2005,19(6):403-414.
[16] JAIN M K,RIDKER P M.Anti-inflammatory effects of statins:clinical evidence and basic mechanisms[J].Nat Rev Drug Discov,2005,4(12):977-987.
[17] NGUYEN K A,LI L,LU D S,et al.A comprehensive review and meta-analysis of risk factors for statin-induced myopathy[J].Eur J Clin Pharmacol,2018,74(9):1099-1109.